Hong Seng expanding healthcare ops with Neogenix, eMedAsia deals

KUALA LUMPUR: Hong Seng Consolidated Bhd, through wholly-owned HS Bio Supplies Sdn Bhd, has signed share sale agreements to buy Neogenix Laboratoire Sdn Bhd and eMedAsia Sdn Bhd.

Author(s): -
Copyright: NSTP
Published on: 2 January 2021
Publication: New Straits Times
Items linked to this story
NST - Sat, 01 2021 CM 021 a
Contact us for more information on License Usage.
Additional fees
Historical Fee
RM50.00
(Includes 8% SST) RM125.60